Advanced Accelerator Applications U.S. facility where Lutathera (PRRT) will be manufactured for clinical use in North America. FDA approval is anticipated by the end of the year. The facility is impressive from state of the art equipment to it's over the top standards and security, and the people are just as awesome. If you are confused about the current status of nuclear medicine scans and treatments for NET cancer in the U. S., please click through to the HNF Zebra Blog by Dr. Eric Liu about Netspot (Ga 68 diagnostic scan kit), which was just approved by FDA, and click on the link in the blog to better understand Lutathera. From Cindy Lovelace, HNF Exec Dir and PNET.
Read below for various news articles, interviews, documents and other resources regarding neuroendocrine cancer treatments and therapies, and the Healing NET Foundation.